Gene polymorphisms identified that are responsible for breast density and cancer risk

It has long been known that breast density, or mammographic density, is a strong risk factor for breast cancer, and that estrogen and progestin hormone therapy increases dense breast tissue. Now, a study published in BioMed Central's open access journal Breast Cancer Research has identified several gene variants in hormone metabolism and growth factor pathways that may be associated with breast density and, hence, breast cancer risk.

Mammographic density relates to the fact that x-rays permeate different types of breast tissue in different ways, leading to white areas on the mammogram. Fatty tissue appears on the mammogram as relatively translucent, whereas dense breast tissue contains more stromal tissue and , appearing as white areas. Women with a breast density of 75% or more have a 4-5 times higher risk of developing than women of the same age with little or no density.

Controversy exists over why breast density is a cancer risk. Many studies suggest that density is at least partially inherited, and twin studies show that genetic factors do play a role in the variation observed. Breast density decreases naturally with older age and menopause, but also increases with hormone therapy. Merete Ellingjord-Dale and co-authors, from academic centers in Norway and Los Angeles, set out to investigate which genes could play a role in determining breast density. Because of the clear involvement of hormones, they were looking particularly for genes involved in hormone metabolism.

Using data from 2,036 women who participated in the Norwegian Program in 2004, and separating the participants into hormone therapy users and non-users, the authors found that different gene variants appeared to be important depending on the women's hormone therapy usage.

There was evidence to suggest that variants in the prolactin (PRL) gene were associated with breast density in users of estrogen and progestin, as well as norethisterone acetate (a common regimen in Nordic countries). In non-users of hormone therapy, variants in the tumor necrosis factor (TNF) and SULT1A1/2 genes were significantly associated with breast density.

The findings suggest that several genes in hormone metabolism and growth factor pathways are indeed implicated in determining , and might increase . Commenting on the findings, lead author, Merete Ellingjord-Dale said, "One reason it has been so difficult to pinpoint which genes are responsible for mammographic density is that the effect of some genetic variants may be amplified in combination with hormone therapy. Consequently in the presence of hormone therapy these genes cause increased density."

She continued, "It is important to consider both the genetic and non-genetic factors simultaneously. Exploring the functional role of gene variants associated with mammographic density could further clarify the biological mechanisms involved. "

Related Stories

Breast tenderness linked to increased breast density

date Oct 24, 2011

(Medical Xpress) -- Post-menopausal women who experience breast tenderness after starting combination hormone therapy have a higher risk of breast cancer than women who don't, a study by researchers with UCLA's Jonsson Comprehensive ...

Breast density tied to specific types of breast cancer

date Jul 27, 2011

Women with breasts that appear dense on mammograms are at a higher risk of breast cancer and their tumors are more likely to have certain aggressive characteristics than women with less dense breasts, according to a study ...

Recommended for you

DNA blood test detects lung cancer mutations

date 21 hours ago

Cancer DNA circulating in the bloodstream of lung cancer patients can provide doctors with vital mutation information that can help optimise treatment when tumour tissue is not available, an international group of researchers ...

Tumors prefer the easy way out

date 23 hours ago

Tumor cells become lethal when they spread. Blocking this process can be a powerful way to stop cancer. Historically, scientists thought that tumor cells migrated by brute force, actively pushing through whatever ...

Brain tumors may be new targets of Ebola-like virus

date 23 hours ago

Brain tumors are notoriously difficult for most drugs to reach, but Yale researchers have found a promising but unlikely new ally against brain cancers—portions of a deadly virus similar to Ebola.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.